• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Biovista Harnesses New Kinds of Augmented and Artificial Intelligence to Address COVID-19 August 25, 2020
  • Repositioning Safety May 22, 2020
  • Artificial Intelligence firm Biovista repositions four promising therapeutics against COVID-19 April 22, 2020
  • Business Development Agent in Japan February 12, 2020
  • High Throughput Layout and Copy Paste July 5, 2019

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

Diabetes drugs for Alzheimer’s disease

September 5, 2018Metabolic Disorders, Nervous System Disorders, Vizit Graphs
Diabetes drugs for Alzheimer’s diseaseChristos Andronis2020-08-03T13:49:59+00:00
Diabetes drugs for Alzheimer’s disease

Repurposing Diabetes drugs for Alzheimer’s disease. View pathways associated with the action of Exenatide in Alzheimer’s. Explore the mechanism of action of GLP-1/GIP dual agonists in Alzheimer’s with Biovista Vizit.

Explore the live graph.

Tags: ALZHEIMER'S DISEASE, CELL DEATH, CELL DIFFERENTIATION, DIABETES, EXENATIDE, GIP, GLP-1, INFLAMMATORY RESPONSE, LIPID METABOLIC PROCESS, LIRAGLUTIDE, METFORMIN, NEURON DEATH, SAXAGLIPTIN, SITAGLIPTIN PHOSPHATE

Post navigation

← Mitochondrial role in Cancer Metastasis
Alzheimer’s and Olfactory impairment →

Vizit Graphs Tag Cloud

CD4 IL6 COAGULATION HELICOBACTER PYLORI INSULIN INFLAMMATION INTERFERON ACE ESCHERICHIA COLI COGNITION TNF STAPHYLOCOCCUS AUREUS AGING LACTATE DEHYDROGENASE LISTERIA MONOCYTOGENES PSEUDOMONAS AERUGINOSA ALZHEIMER'S DISEASE AUTOPHAGY NFKB1 CELL PROLIFERATION IFNG IMMUNITY RAS IL2 IL1B CASP3 ACE2 APOPTOTIC PROCESS CANDIDA ALBICANS TMPRSS2 CELL DIFFERENTIATION COVID-19 ANGIOTENSIN II METFORMIN IL10 MYALGIA ALBUMIN RHEUMATOID ARTHRITIS PARKINSON DISEASE PD-1 NEUTROPHILS INFLAMMATORY RESPONSE CANCER SARS-COV-2 IMMUNE RESPONSE

© 2021 Biovista Vizit All Rights Reserved.